The Co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q 10 ameliorates hyperlipidemia in high fat diet fed rats

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 11, 2009, Pages 6741-6746

  Ratnam, D Venkat ^a   Chandraiah, G ^b   Meena, A K ^b   Ramarao, P ^b   Kumar, M N V Ravi ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Antioxidants; Bioavailability; Hyperlipidemia; Nanoparticles

Indexed keywords

ANTIOXIDANT COMBINATIONS; ANTIOXIDANTS; BIOAVAILABILITY; CHOLESTEROL-LOWERING EFFECTS; ELLAGIC ACID; HIGH-FAT DIET; HYPERLIPIDEMIA; POST TREATMENT; TYPE-2 DIABETES;

ACIDS; BIOCHEMISTRY; ECOLOGY; GLUCOSE; NUTRITION; RATS;

NANOPARTICLES;

ANTIOXIDANT; DRUG CARRIER; DRUG DERIVATIVE; ELLAGIC ACID; NANOPARTICLE; UBIDECARENONE; UBIQUINONE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG FORMULATION; FAT INTAKE; HYPERLIPIDEMIA; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; DIETARY FATS; DRUG CARRIERS; DRUG COMPOUNDING; ELLAGIC ACID; HYPERLIPIDEMIAS; MALE; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; UBIQUINONE;

EID: 70350322267     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.1461     Document Type: Article

References (38)

1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, Diabetes Care 27, 1047 (2004).
2. V. Snow, M. D. Aronson, E. R. Hornbake, C. Mottur-Pilson, and K. B. Weiss, Ann. Intern. Med. 140, 644 (2004).
3. K. Pyorala, T. R. Pederson, and J. Kjekshus, Diabetes Care 20, 614 (1997).
4. P. D. Thompson, P. Clarkson, and R. H. Karas, J. Am. Med. Assoc. 289, 1681 (2003).
5. D. V. Ratnam, D. D. Ankola, V. Bhardwaj, D. K. Sahana, and M. N. V. R. Kumar, J. Control. Rel. 113, 189 (2006).
6. Z. S. Warwick and S. S. Schiffman, Neurosci. Biobehavioral Rev. 16, 585 (1992).
7. M. Matsuzki, T. Kita, H. Mabuchi, Y. Matsuzawa, N. Nakaya, S. Oikawa, Y. Saito, J. Sasaki, K. Shimamoto, H. Itakura, and the J-LIT Study Group, Circ. J. 66, 1087 (2002).
8. M. Alkawa, E. Rabkin, S. Sugiyama S. J. Voglic, Y. Fukumoto, Y. Furukawa, M. Shiomi, F. J. Schoen, and P. Libby, Circulation 103, 276 (2001).
9. P. M. Ridker, C. P. Cannon, D. Morrow, N. Rifai, L. M. Rose, C. H. McCabe, M. A. Pfeffer, and E. Braunwald, N. Engl. J. Med. 352, 20 (2005).
10. W. F. Riesen, H. Engler, M. Rish, W. Korte, and G. Noseda, Eur. Heart J. 23, 794 (2002).
11. R. W. van Etten, E. J. P. de Koning, M. L. Honing, E. S. Stroes, C. A. Gaillard, and T. J. Rabelink, Arterioscler. Thromb. Vasc. Biol. 22, 799 (2002).
12. M. M. Engler, M. B. Engler, M. J. Malloy, E. Y. Chiu, M. C. Schloetter, S. M. Paul, M. Stuehlinger, K. Y. Lin, J. P. Cooke, J. D. Morrow, P. M. Ridker, N. Rifai, E. Miller, J. L. Witztum, and M. Mietus-Snyder, Circulation 108, 1059 (2003).
13. F. Nigris, S. Williams-Ignarro, L. O. Lerman, E. Crimi, C. Botti, G. Mansueto, F. P. D'Armiento, G. D. Rosa, V. Sica, L. J. Ignarro, and C. Napoli, Proc. National Acad. Sci. 102, 4896 (2005).
14. F. L. Crane, J. Am. Coll. Nutr. 20, 591 (2001).
15. J. Kucharska, Z. Braunova, O. Ulicna, L. Zlatos, and A. Gvozdjakova, Physiol. Res. 49, 411 (2000).
16. M. V. Miles, J. A. Morrison, P. S. Horn, P. H. Tang, and A. J. Pesce, Clin. Chim. Acta 344, 173 (2004).
17. H. Ueda, K. Kawanishi, and M. Moriyasu, Biol. Pharm. Bull. 27, 1584 (2004).
18. D. V. Ratnam, G. Chandraiah, K. Sonaje, B. Viswanad, V. Bhardwaj, P. Ramarao, and M. N. V. R. Kumar, J. Biomed. Nanotechnol. 4, 33 (2008).
19. D. V. Ratnam, V. Bhardwaj, and M. N. V. R. Kumar, Talanta 70, 387 (2006).
20. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, Pharmacol. Res. 52, 313 (2005).
21. K. H. Arun, C. L. Kaul, and P. Ramarao, Pharmacol. Res. 50, 561 (2004).
22. F. Delie, Adv. Drug. Deliv. Rev. 34, 221 (1998).
23. N. Hussain, V. Jaitley, and A. T. Florence, Adv. Drug Deliv. Rev. 50, 107 (2001).
24. V. Bhardwaj, S. Hariharan, I. Bala, A. Lamprecht, N. Kumar, R. Panchagnula, and M. N. V. R. Kumar, J. Biomed. Nanotechnol. 1, 235 (2005).
25. I. Bala, V. Bhardwaj, S. Hariharan, S. V. Kharade, N. Roy, and M. N. V. R. Kumar, J. Drug Target. 14, 27 (2005).
26. K. Sonaje, J. Italia, G. Sharma, V. Bhardwaj, K. Tikoo, and M. N. V. R. Kumar, Pharm. Res. 24, 899 (2007).
27. J. L. Italia, D. K. Bhatt, V. Bhardwaj, K. Tikoo, and M. N. V. R. Kumar, J. Control. Rel. 119, 197 (2007).
28. G. Mittal, D. K. Sahana, V. Bhardwaj, and M. N. V. R. Kumar, J. Control. Rel. 119, 77 (2007).
29. D. D. Ankola, B. Viswanad, V. Bhardwaj, P. Ramarao, and M. N. V. R. Kumar, Eur. J. Pharm. Biopharm. 67, 361 (2007).
30. A. K. Meena, D. V. Ratnam, G. Chandraiah, D. D. Ankola, P. Ramarao, and M. N. V. R. Kumar, Lipids 43, 231 (2008).
31. J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum, Diabetes Care 31, 811 (2008).
32. E. Manzato, A. Zambon, A. Lapolla, S. Zambon, and L. Braghetto, Diabetes Care 16, 469 (1993).
33. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults, JAMA 285, 2486 (2001).
34. J. D. Brunzell, W. R. Hazzard, A. G. Motuskly and E. L. Bierman, Metabolism 24, 1115 (1975).
35. L. Packer, S. U. Weber, and G. Rimbach, J. Nutr. 131, 369S (2001).
36. J. W. Lampe, Am. J. Clin. Nutr. 70 suppl, 475S (1999).
37. D. Pratico, Atherosclerosis 181, 215 (2005).
38. J. Davda and V. Labhasetwar, Int. J. Pharm. 233, 51 (2002).